Children with sickle cell disease are about 200 times more likely to have a stroke than children without the condition.
Blood disorders are health conditions that affect the blood and how it works in the body. Some blood disorders make it harder for the blood to clot. Others affect how blood cells carry oxygen through the body.
Blood disorders can be passed down in families or develop later in life. Through clinical research, we are looking for better ways to manage and treat blood disorders and support people living with these conditions.
Sickle cell disease is a blood condition that is passed down in families. It affects hemoglobin, a part of red blood cells that carries oxygen through the body. In people with sickle cell disease, some red blood cells can become hard, sticky, and shaped like a crescent instead of being round and flexible.
These cells may break apart too soon. This can cause the body to have too few red blood cells, which is called anemia. The cells can also get stuck in small blood vessels and block the flow of blood and oxygen. These blockages can cause sudden, severe pain. Sickle cell disease may also cause tiredness, infections, stroke, or damage to organs over time.
The signs and effects can be different for each person. Regular care from a healthcare team can help manage symptoms and lower the chance of serious health problems.
Hemophilia is a rare bleeding condition. It happens when the blood does not clot the way it should. The blood uses proteins called clotting factors to help stop bleeding. People with hemophilia do not have enough of certain clotting factors, so bleeding may last longer.
Most people with hemophilia are born with it. It is often passed down in families and is more common in males, but females can also have hemophilia or have symptoms. About 1 out of 3 babies diagnosed with hemophilia have no known family history of the condition.
People with hemophilia may bleed longer than expected. Bleeding can also happen inside the body, including in the joints. Treatment depends on the type and how serious the condition is. Treatment may be used to stop bleeding or given regularly to help prevent it.
Sickle cell disease and hemophilia are rare but serious blood conditions. They can affect people, families, and communities in many ways. These facts show why research is important. Clinical research may help find better ways to diagnose, care for, and treat these conditions.
Children with sickle cell disease are about 200 times more likely to have a stroke than children without the condition.
Sickle cell disease affects about 100,000 people in the United States. More than 90% are non-Hispanic Black or African American, and about 3%-9% are Hispanic or Latino.
About 3 out of 4 people with hemophilia in the United States have hemophilia A. Hemophilia A happens when the body does not have enough of a clotting protein called factor VIII.
About 1 out of 4 people with hemophilia in the United States have hemophilia B. Hemophilia B happens when the body does not have enough of a clotting protein called factor IX.
Knowing the type of hemophilia helps the healthcare team choose the right treatment. The treatment may replace factor VIII or factor IX, or help the blood clot in a similar way.
Explore ongoing blood disorder clinical studies, including trials that are currently enrolling and early listings for studies that are not yet recruiting. Available details may vary by study.
ENROLLING
A Research Study to Evaluate How Well a Study Medicine Works in People With Sickle Cell Disease (HIBISCUS 2)
Condition: Sickle Cell Disease | Study ID: NN7535-7807
ENROLLING
A Research Study Looking at How Different Doses of Study Medicine Work in the Body of People With Hemophilia A (VOYAGER 2)
Condition: Hemophilia A | Study ID: NN7442-8454